Ruffolo, Robert R.
GlaxoSmithKline plc.,
United Kingdom
2025 Rank: 33267
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 274 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33267 | 36841 |
| Total Cites | 9387 | 10075 |
| H-index | 51 | 53 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 612 | 615 |
| Number of Single+First Authored Papers | 114 | 114 |
| Total Cites to Single+First Authored Papers | 2452 | 2510 |
| Number of Single+First+Last Authored Papers | 224 | 224 |
| Total Cites to Single+First+Last Authored Papers | 5533 | 5825 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7110 | 7367 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.37 |
| Self-Citation Percentage |
6.83%
|
|
Ruffolo, Robert R.
Pfizer Inc.,
United States
2024 Rank: 31268
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 252 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31268 | 34687 |
| Total Cites | 9191 | 9850 |
| H-index | 51 | 53 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 27 | 27 |
| Total Cites to Single Authored Papers | 582 | 585 |
| Number of Single+First Authored Papers | 113 | 113 |
| Total Cites to Single+First Authored Papers | 2383 | 2440 |
| Number of Single+First+Last Authored Papers | 220 | 220 |
| Total Cites to Single+First+Last Authored Papers | 5409 | 5684 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6949 | 7194 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.37 |
| Self-Citation Percentage |
6.69%
|
|
Ruffolo, Robert R.
Pfizer Inc.,
United States
2023 Rank: 29098
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 245 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29098 | 31983 |
| Total Cites | 9041 | 9699 |
| H-index | 50 | 53 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 27 | 27 |
| Total Cites to Single Authored Papers | 562 | 565 |
| Number of Single+First Authored Papers | 113 | 113 |
| Total Cites to Single+First Authored Papers | 2337 | 2393 |
| Number of Single+First+Last Authored Papers | 219 | 219 |
| Total Cites to Single+First+Last Authored Papers | 5320 | 5593 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6815 | 7059 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.37 |
| Self-Citation Percentage |
6.78%
|
|
Ruffolo, Robert R.
Pfizer Inc.,
United States
2022 Rank: 26707
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 217 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26707 | 29152 |
| Total Cites | 8858 | 9514 |
| H-index | 49 | 52 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 27 | 27 |
| Total Cites to Single Authored Papers | 538 | 541 |
| Number of Single+First Authored Papers | 113 | 113 |
| Total Cites to Single+First Authored Papers | 2275 | 2331 |
| Number of Single+First+Last Authored Papers | 219 | 219 |
| Total Cites to Single+First+Last Authored Papers | 5213 | 5486 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6663 | 6905 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.38 |
| Self-Citation Percentage |
6.90%
|
|
Ruffolo, Robert R.
Pfizer Inc.,
United States
2021 Rank: 25235
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 216 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25235 | 27829 |
| Total Cites | 8701 | 9352 |
| H-index | 49 | 52 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 27 | 27 |
| Total Cites to Single Authored Papers | 517 | 520 |
| Number of Single+First Authored Papers | 113 | 113 |
| Total Cites to Single+First Authored Papers | 2221 | 2277 |
| Number of Single+First+Last Authored Papers | 219 | 219 |
| Total Cites to Single+First+Last Authored Papers | 5118 | 5389 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6528 | 6768 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.38 |
| Self-Citation Percentage |
6.96%
|
|
Ruffolo, Robert R.
Pfizer Inc.,
United States
2020 Rank: 22706
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 188 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22706 | 25064 |
| Total Cites | 8529 | 9175 |
| H-index | 48 | 52 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 26 | 26 |
| Total Cites to Single Authored Papers | 497 | 500 |
| Number of Single+First Authored Papers | 111 | 111 |
| Total Cites to Single+First Authored Papers | 2150 | 2205 |
| Number of Single+First+Last Authored Papers | 217 | 217 |
| Total Cites to Single+First+Last Authored Papers | 5008 | 5278 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6381 | 6617 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.39 |
| Self-Citation Percentage |
7.04%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.